Eliciting population preferences for mass colorectal cancer screening organization

Medical Decision Making

Volumn 30, Issue 2, 2010, Pages 224-233

  Nayaradou, Maximilien ^a,b   Berchi, Célia ^a   Dejardin, Olivier ^a   Launoy, Guy ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ PARIS DAUPHINE   (France)

Author keywords

Colorectal cancer; Discrete choice experiments; Mass screening; Population preferences; Stated preferences

Indexed keywords

AGED; ARTICLE; ATTITUDE TO HEALTH; COLORECTAL TUMOR; DECISION MAKING; EARLY DIAGNOSIS; ECONOMICS; FEMALE; FRANCE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATIENT ATTITUDE; QUESTIONNAIRE; SOCIOECONOMICS;

AGED; ATTITUDE TO HEALTH; CHOICE BEHAVIOR; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PATIENT PREFERENCE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS;

EID: 77950614324     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X09342747     Document Type: Article

References (35)

1. Parkin DM, Whelan SL, Ferlay J., Teppo L., Thomas DB Cancer Incidence in Five Continents. Vol. VIII. Lyon, France: IARC ; 2002.
2. Remontet L., Estève J., Bouvier AM, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique. 2003 ; 51: 3-30. (Pubitemid 36813955)
3. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996 ; 348: 1472-1477.
4. Kronborg O., Fenger C., Olsen J., Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996 ; 348: 1467-1471.
5. Winawer SJ, Fletcher RH, Miller L., et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997 ; 112: 594-642.
6. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med. 2000 ; 343: 162-168.
7. Allison JE, Tekawa IS, Ransom LJ, Adrain AL A comparison of fecal occult-blood tests for colorectal cancer screening. N Engl J Med. 1996 ; 334: 155-159.
8. Castiglione G., Sala P., Ciatto S., et al. Comparative analysis of results of guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening in two oncological institutions. Eur J Cancer Prev. 1994 ; 3: 399-405.
9. Guittet L., Bouvier V., Mariotte N., et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut. 2007 ; 56: 210-214.
10. Gyrd-Hansen D., Sàgaard J. Analysing public preferences for cancer screening programmes. Health Econ. 2001 ; 10: 617-634.
11. Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L., Kulin NA Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health. 2007 ; 10: 415-430.
12. Herbert C., Launoy G. Le dépistage organisé du cancer colorectal en France: systeèmes de soins, logiques collectives et logiques individuelles. Sante Publique. 1999 ; 4: 391-407.
13. Gyrd-Hansen D., Slothuus U. The citizens preferences for financing public health care: a Danish survey. Int J Health Care Finance Econ. 2002 ; 2: 25-36.
14. Scott A., Watson MS, Ross S. Eliciting preferences of the community for out of hours care provided by general practitioners: a stated preference discrete choice experiment. Soc Sci Med. 2003 ; 56: 803-814.
15. Ryan M., Hughes J. Using conjoint analysis to assess womens preferences for miscarriage management. Health Econ. 1997 ; 6: 261-274.
16. King MT, Hall J., Lancsar E., et al. Patient preferences for managing asthma: results from a discrete choice experiment. Health Econ. 2007 ; 16: 703-717. (Pubitemid 47096463)
17. Berchi C., Dupuis JM, Launoy G. The reasons of general practitioners for promoting colorectal cancer mass screening in France. Eur J Health Econ. 2006 ; 7: 91-98.
18. Belkar R., Fiebig D., Haas M., Viney R. Why worry about awareness in choice problems? Econometric analysis of screening for cervical cancer. Health Econ. 2006 ; 15: 33-47.
19. Kenkel DS The demand for preventative medical care. App Econ. 1994 ; 26: 313-325.
20. Mullahy J. Itll only hurt a second? Microeconomic determinants of who gets flu shots. J Health Econ. 1999 ; 8: 9-24.
21. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993 ; 328: 1365-1371.
22. Tazi A., Faivre J., Lejeune C., Benhamiche AM, Dassonville F. Performances du test Hemoccult® dans le dépistage des cancers et des adénomes colorectaux. Résultats de cinq campagnes de dépistage en Saàne-et-Loire. Gastroenterol Clin Biol. 1999 ; 23: 575-580.
23. Drakopoulos SA Hierarchical choice in economics. J Econ Surv. 1994 ; 8: 133-153.
24. Nexoe J., Gyrd-Hansen D., Kragstrup J., Kristiansen IV, Nielsen JB Danish GPs perception of disease risk and benefit of prevention. Fam Pract. 2002 ; 19: 3-6. (Pubitemid 34173267)
25. Scott A. Eliciting GPs preferences for pecuniary and non-pecuniary job characteristics. J Health Econ. 2001 ; 20: 329-347.
26. Thurstone L. A law of comparative judgement. Psychol Rev. 1927 ; 34: 273-286.
27. McFadden D. Conditional logit analysis of qualitative choice behaviour. In: Zarembka P, ed. Frontiers in Econometrics. New York: Academic Press ; 1974.
28. Manski CF The structure of random utility models. Theory Des. 1977 ; 8: 229-254.
29. Snijders TAB, Bosker RJ Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modelling. Thousand Oaks, CA: Sage ; 1999.
30. Propper C. The disutility of time spent on UK National Health Service waiting lists. J Hum Resour. 1995 ; 30: 677-700.
31. Salkeld GP, Solomon MJ, Short L., Ward J. Measuring the importance of attributes that influence consumer attitudes to colorectal cancer screening. ANZ J Surg. 2003 ; 73: 128-132.
32. Faivre J., Arveux P., Milan C., Durand G., Lamour J., Bedenne L. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study. Eur J Cancer Prev. 1991 ; 1: 49-55.
33. Launoy G., Veret JL, Richir B., et al. Involvement of general practitioners in mass screening: experience of a colorectal cancer mass screening programme in the Calvados region (France). Eur J Cancer Prev. 1993 ; 2: 229-232.
34. Cole SR, Young GP, Byrne D., Guy JR, Morcom J. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. J Med Screen. 2002 ; 9: 147-152.
35. Subramanian S., Klosterman M., Amonkar MM, Hunt TL Adherence with colorectal cancer screening guidelines: a review. Prev Med. 2004 ; 38: 536-550.